Explore Lichen China Limited's recent 6-K report detailing Nasdaq delisting alerts, compliance issues, and management's appeal strategy. Key for investors assessing risk.
Discover Lichen China Limited's transformative 6-K filing, detailing capital increases, name change, and shareholder approvals. Key insights into the company's strategic future.
Explore Lichen China Limited's SEC Form 6-K for February 2025, detailing its acquisition of Bondly Enterprises to boost AI capabilities and business integration.
Discover Lichen China Limited's recent $5.9M funding success through two direct offerings, including share details, proceeds, and compliance insights.
Explore Lichen China Limited's recent $2.7 million registered direct offering, including share details, use of proceeds, and strategic implications for future growth.
Explore Lichen China Limited's Form 6-K filing detailing their AI model launch with JD Technology. Key insights include filing dates, CEO signature, and future annual reports.